Comparing microwave ablation and radiation for early lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This study compares two non-surgical treatments for early-stage lung cancer: microwave ablation (a procedure that uses heat to destroy the tumor) and stereotactic body radiotherapy (a precise type of radiation). The goal is to see if these treatments are equally effective in controlling the cancer while slowing down progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have early non-small cell lung cancer (stage IA) that is 3 cm or smaller and has not spread to lymph nodes or other organs.
- Either you are not a candidate for surgery, or you prefer not to have surgery after discussing with your doctors.
- Your tumor must be suitable for both microwave ablation (a treatment that uses heat to destroy the tumor) and stereotactic body radiation therapy (SBRT, a precise type of radiation).
- You have not had radiation to the chest that would overlap with the planned treatment area.
- You are able to give informed consent and willing to be randomly assigned to either treatment group.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer, more precise way of giving radiation for lung cancer tumors that are near the center of the chest. The goal is to see if using a smaller treatment area can reduce side effects while still killing the cancer.
This study looks at two treatment options for early-stage lung cancer in patients who are considered 'high-risk' because of poor lung function or other health issues. The goal is to compare outcomes from a surgical approach (removing just the tumor and a small rim of tissue) versus a precise, shorter course of radiation therapy.
This study looks at two ways to treat early-stage lung cancer: using heat from a tiny probe passed through the airways to kill the tumor (microwave ablation), or surgery to remove the tumor and some surrounding tissue. The goal is to find which approach is more effective and safer for people with this type of lung cancer.
This study tests a new, less invasive way to treat lung cancer using microwave energy delivered through a thin tube inserted into the airway. It is for people with small, confirmed lung tumors who are already being considered for surgery, and who cannot or prefer not to have blood thinners.
This trial compares two types of radiofrequency ablation (a heat-based treatment) for early-stage lung cancer that is located in the outer parts of the lung. One approach uses a needle through the chest wall, the other uses a bronchoscope through the airways. The goal is to see which works better for people who cannot have surgery.
This study compares two minimally invasive treatments—bronchoscopic thermal vapor ablation (BTVA) and microwave ablation (MWA)—for people with COPD and early-stage lung cancer. Both treatments aim to destroy cancer cells without surgery, which may be a good option if you cannot or prefer not to have surgery.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.